|
Opening
Session: Sunday, January 31,1999
|
| 5–7
pm |
Bernard
Fields Memorial Lecture:
The Role of the HIV-1 Envelope Glycoproteins in Virus Entry and Pathogenesis
Joseph Sodroski
Dana-Farber Cancer Inst., Boston, MA
Keynote Lecture: The Origin
of HIV-1: A Puzzle Solved?
Beatrice Hahn
Univ. of Alabama, Birmingham
|
| time |
Monday
February 1, 1999 |
Tuesday
February 2, 1999 |
Wednesday
February 3, 1999 |
Thursday
February 4, 1999 |
| 8:30–9am |
Lecture
Session 2.
Antiretroviral Therapy in Adults
Stefano Vella
Inst. Superiore di Sanita,
Rome, Italy |
Lecture
Session
32.
HIV Tat and Rev: What They Do and How They Do It
Bryan Cullen
Howard Hughes Med. Inst.
Duke Univ. Med. Ctr., Durham, NC |
Lecture
Session
60.
Structure and Assembly of the HIV Capsid
Wesley Sundquist
Univ. of Utah Sch. of Med.
|
8–10
am
Special Symposium
Immune
Reconstitution and Clinical Implications
|
| 9–9:30am
|
Lecture
Session 3.
Pediatric Antiretroviral Therapy
Katherine Luzuriaga
Univ.of Massachusetts, Worcester |
Lecture
Session
33.
Care for HIV in the US: Access, Quality,
Cost, and Consequences
Sam Bozzette
Univ. of California, San Diego |
Lecture
Session
61.
T-Cell Immunity During Acute and Chronic Viral
Infection
Rafi Ahmed
Emory Univ., Atlanta, GA |
| 10am–
12:30pm |
Slide Session 4.
Pathogenesis
Slide Session 5.
Antiretroviral Therapy: New Agents and Treatment Naive Patient Populations
Slide Session 6.
Immunologic Reserve and Reconstitution
|
Slide
Session 34.
Pathogenesis and Treatment of Opportunistic Diseases
Slide Session 35.
Cellular Immunity to HIV, SIV, and HHV-8
Slide Session 36.
Maternal-Fetal/
Pediatrics/Women's Health
Slide Session 37.
Epidemiology and Infection Control |
Slide Session 62. Antiretroviral
Therapy: Treatment Experienced Patient Populations
Slide Session 63.
Co-Receptors/
Infectivity Determinants
Slide Session 64.
HIV Regulation: Accessory Genes
|
late
breaker session |
|
2-4pm
|
Symposia
Session 7.
Metabolic
Complications of Antiviral Therapy: Clinical Implications
Symposia
Session
8.
Interventions
in Perinatal Transmission
Symposia
Session
9.
Chemokine
Receptors and Genetic Markers in HIV Disease Pathogenesis
|
Symposia
Session
38.
HIV-Related
Neoplasia: Advances and Controversies
Symposia
Session
39.
Accessory
Gene Functions
Symposia
Session
40.
Live Vaccine
Vectors
|
Symposia
Session
65.
Update
on HIV Epidemiology and Prevention
Symposia
Session
66.
Antiretroviral
Resistance: Basic Mechanisms and Clinical Issues
Symposia
Session
67.
Structure/Assembly
|
|
4:30–
6:30pm |
Poster
Session 10. HIV Specific Humoral and Cell Mediated Immunity
Poster
Session 11. HIV Vaccines: Progress and Challenges
Poster
Session 12. Topics in Immunology and Immunopathogenesis
Poster
Session 13. Pathogenesis: Selected Observations
Poster
Session 14. Virology: Selected Observations
Poster
Session 15. Antiretroviral Therapy: Adherence and Quality of Life
Poster
Session 16. Antiretroviral Therapy: Access and Cost
Poster
Session 17. Resistance to Antiretroviral Drugs
Poster
Session 18. Genotypic and Phenotypic Characterization: Predictors
of Therapeutic Success or Failure
Poster
Session 19. Genotypic and Phenotypic Assays for Drug Resistance
Poster
Session 20. HIV Quantification Assays: Comparisons of Sensitivity
and Specificity
Poster
Session 21. Detection and Characterization of HIV-1 in Patients
on Potent Therapy
Poster
Session 22. Predictors of Durable Responses to Antiretroviral Therapy
Poster
Session 23. Diagnostic Tools for the Detection and Management of
HIV Infection
Poster
Session 24. Pathogenesis and Treatment of Fungal Infections
Poster
Session 25. Hepatitis Viruses and HIV Co-Infection
Poster
Session 26. HHV-8 and other HIV-Related Malignancies
Poster
Session 27. Infection Control
Poster
Session 28. Issues in HIV Transmission: Viral Load in Genital Secretions/Drug
Resistant Variants/Other Issues
Poster
Session 29. Perinatal Transmission
|
Poster
Session 41. Neuropathogenesis
Poster
Session 42. Compartmentalization of HIV in vivo
Poster
Session 43. Models of Viral Dynamics and Compartmentalization
Poster
Session 44. HIV: Interaction with Cellular Components
Poster
Session 45. HAART: Effects on Repertoire, Lymphocyte Dynamics, and
General Immune Response
Poster
Session 46. HAART: Reconstitution of HIV Specific Immunity
Poster
Session 47. Immune Based and Genetic Therapies
Poster
Session 48. Pharmacology of Antiretroviral Agents
Poster
Session 49. Miscellaneous Antiretroviral Therapy
Poster
Session 50. Hydroxyurea in the Treatment of HIV Infection
Poster
Session 51. Antiretroviral Therapy: Clearance of HIV from the Central
Nervous System
Poster
Session 52. Central Nervous System Opportunistic Complications
Poster
Session 53. Antiretroviral Therapy Issues in Infants and Children
Poster
Session 54. Pathogenesis and Treatment of Mycobacterial Infections
Poster
Session 55. Pathogenesis and Treatment of Cytomegalovirus Infections
Poster
Session 56. HIV Infection in Women: Special Issues
Poster
Session 57. Epidemiology and Infection Control: Risk Populations
Poster
Session 58. Miscellaneous Diagnostics |
Poster
Session 68. Chemokine and Chemokine Receptor Activity
Poster
Session 69. Cytokine-Chemokine Interactions
Poster
Session 70. Immunopathogenesis of Primary HIV Infection
Poster
Session 71. Genetic, Immunologic, and other Correlates of Disease
Progression
Poster
Session 72. Virology: Nef, Vpr, Vpu
Poster
Session 73. Virology: Reverse Transcription
Poster
Session 74. Antiretroviral Therapy: Reverse Transcriptase and Protease
Inhibitors
Poster
Session 75. Antiretroviral Therapy: Inhibitors of Viral Fusion and
Entry
Poster
Session 76. Antiretroviral Therapy: Novel Approaches
Poster
Session 77. Clinical Trials in Patients Naive to Antiretroviral Drugs
Poster
Session 78. Primary HIV Infection: Uncontrolled Clinical Trials
Poster
Session 79. Metabolic Complications of Antiretroviral Therapy
Poster
Session 80. Metabolic Complications of Antiretroviral Therapy in Women
Poster
Session 81. Mechanisms Responsible for Metabolic Complications of
Antiretroviral Therapy
Poster
Session 82. Therapeutic Interventions for Metabolic Complications
of Antiretroviral Therapy
Poster
Session 83. Miscellaneous Complications of Antiretroviral Therapy
Poster
Session 84. Pregnancy Outcomes: Impact of Mode of Delivery and Antiretroviral
Therapies
Poster
Session 85. Changing Incidence and Epidemiology of Opportunistic Complications
Poster
Session 86. PCP, Wasting/Protozoa, and other Organ System Complications
Poster
Session 87. Molecular Epidemiology
Poster
Session 88. Diagnostic Detection and Quantification of HIV Subtypes
|
| 5:30–7pm |
Poster
Discussion 30. HIV Vaccines: Progress and Challenges
Poster
Discussion 31. Diagnostic Tools for the Detection and Management of
HIV Infection |
Poster
Discussion 59. HIV Infection in Women: Special Issues |
|
